抗酸药市场 - 全球行业规模、份额、趋势、机会和预测，按类型（片剂、液体、其他）、按最终用途（零售药房、医院药房、网上药房）、按地区和竞争进行细分，2020-2030 年预测

2024 年全球抗酸剂市场价值为 68.7 亿美元，预计到 2030 年将达到 84.1 亿美元，预测期内复合年增长率为 3.43%。抗酸药是一类非处方药（OTC）或处方药，主要用于缓解与胃酸过多和胃肠道酸性相关的症状。它们透过中和或减少胃内容物的酸度来发挥作用，有助于缓解胃灼热、消化不良和胃部不适等症状。抗酸药含有碱性活性成分。食用后，这些成分会与胃中多余的盐酸发生反应并中和该物质，从而提高 pH 值并降低酸度。抗酸药物可作为化学缓衝剂，将胃的 pH 值维持在正常或较低的酸性范围内。这种缓衝作用有助于减轻酸性胃内容物逆流至食道所引起的不适，而逆流至食道是导致胃灼热的常见原因。抗酸药物通常用于缓解胃灼热、胃酸倒流、消化不良和胃部不适的症状。它们可以快速缓解症状，适合短期治疗轻度至中度酸性相关疾病。不健康的饮食习惯，包括食用辛辣和酸性食物以及不规则的饮食时间，都会导致酸相关疾病。这些饮食习惯的改变导致了对抗酸药物的需求。全球老化人口更容易患上酸性相关疾病，而且这种疾病通常随着年龄的增长而变得更加常见。随着老年人口的增长，对抗酸药的需求也随之增加。抗酸药是无需处方的非处方药（OTC），这使得消费者可以轻鬆获得它们。这种便利鼓励了自我药疗并推动了销售。製药公司不断创新开发新的抗酸剂型，为消费者提供更广泛的、更有效、更快的产品。

主要市场驱动因素

改变饮食习惯

主要市场挑战

通用竞争

主要市场趋势

电子商务与网路零售

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：顾客之声

第 5 章：全球抗酸药市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按类型（片剂、液体、其他）
  • 依最终用途（零售药局、医院药局、网路药局）
  • 按地区
  • 按公司分类（2024）
• 市场地图

第 6 章：亚太地区抗酸药市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 印度
  • 澳洲
  • 日本
  • 韩国

第 7 章：欧洲抗酸药市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 德国
  • 西班牙
  • 义大利
  • 英国

第 8 章：北美抗酸药物市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 墨西哥
  • 加拿大

第 9 章：南美洲抗酸药市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲抗酸药市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 最新动态
• 产品发布
• 合併与收购

第 13 章：全球抗酸药市场：SWOT 分析

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章： 大环境分析

第 16 章：竞争格局

• Bayer AG
• GlaxoSmithKline plc
• Boehringer Ingelheim International GmbH
• Dr Reddy's Laboratories Ltd.
• Sanofi SA
• Reckitt Benckiser Group plc.
• Sun Pharmaceuticals Ltd
• Takeda Pharmaceutical Company Limited
• Pfizer Inc.
• Procter & Gamble Co.

第 17 章：策略建议

第18章调查会社について・免责事项

Global Antacids Market was valued at USD 6.87 billion in 2024 and is expected to reach USD 8.41 billion by 2030 with a CAGR of 3.43% during the forecast period. Antacids are a category of over the counter (OTC) or prescription medications that are primarily used to relieve symptoms associated with excessive stomach acid and acidity in the gastrointestinal tract. They work by neutralizing or reducing the acidity of the stomach's gastric contents, which can help alleviate symptoms such as heartburn, acid indigestion, and upset stomach. Antacids contain active ingredients that are alkaline (basic) in nature. When consumed, these ingredients react with and neutralize the excess hydrochloric acid in the stomach, raising the pH level and reducing the acidity. Antacids act as chemical buffers, maintaining the pH of the stomach within a normal or less acidic range. This buffering effect helps alleviate the discomfort caused by the regurgitation of acidic stomach contents into the esophagus, which is a common cause of heartburn. Antacids are typically used to relieve symptoms of heartburn, acid reflux, acid indigestion, and upset stomach. They can provide rapid relief, making them suitable for short-term management of mild to moderate acid-related conditions. Unhealthy dietary habits, including the consumption of spicy and acidic foods, and irregular eating schedules, contribute to acid-related disorders. These dietary changes drive the need for antacids. The global aging population is more prone to acid-related disorders, which often become more common with age. As the elderly demographic grows, so does the demand for antacids. The availability of antacids as over the counter (OTC) medications without a prescription makes them easily accessible to consumers. This convenience encourages self-medication and drives sales. Pharmaceutical companies continuously innovate and develop new antacid formulations, offering consumers a broader range of products that are more effective and faster-acting.

Key Market Drivers

Changing Dietary Habits

Spicy and acidic foods, such as citrus fruits, tomatoes, and foods high in spices or vinegar, can trigger or exacerbate heartburn and acid reflux. As people incorporate these foods into their diets, they may experience acid-related discomfort and seek relief through antacids. Diets high in fat can slow down digestion and increase the risk of acid reflux. Fast food and processed foods, which are often high in fat, contribute to dietary habits that can lead to heartburn and indigestion. Overeating, especially in a single large meal, can put pressure on the lower esophageal sphincter (LES), allowing stomach acid to flow back into the esophagus. People with a tendency to consume big meals may experience heartburn, making antacids a go-to solution. Late-night eating can disrupt sleep patterns and increase the risk of acid reflux. As individuals develop habits of eating close to bedtime, they may experience acid-related discomfort, prompting the use of antacids.

Skipping meals or eating irregularly can lead to fluctuations in stomach acid production, increasing the likelihood of heartburn and indigestion when food is finally consumed. For some individuals, specific foods act as triggers for heartburn or indigestion. These trigger foods can vary from person to person but often include coffee, chocolate, alcohol, and mint. As people consume these foods, they may experience symptoms that lead to antacid use. Obesity is a significant risk factor for acid reflux and GERD. Dietary habits that contribute to weight gain can indirectly drive the demand for antacids as obese individuals are more prone to acid-related disorders. Diets high in processed and sugary foods can contribute to gastrointestinal issues and heartburn. As these diets become more common, the demand for antacids may increase. The consumption of caffeinated beverages like coffee and carbonated drinks can relax the LES and increase stomach acid production, potentially leading to heartburn. The globalization of food and the popularity of international cuisines can introduce people to new and spicy foods, which may be less familiar to their digestive systems and increase the likelihood of heartburn. This factor will help in the development of the Global Antacids Market.

Key Market Challenges

Generic Competition

As patents for branded antacid medications expire, generic drug manufacturers are legally allowed to produce and market their versions of the same medications. This leads to an increase in the availability of generic antacids. Generic antacids are typically more cost-effective than their branded counterparts. This price advantage is attractive to cost-conscious consumers, healthcare providers, and healthcare systems. The proliferation of generic antacid products can fragment the market, making it more challenging for branded antacids to maintain market share and premium pricing. Many consumers trust generic medications, believing that they are equivalent in quality and efficacy to their branded counterparts. This trust further drives the demand for generic antacids.

Generic antacids must meet the same regulatory standards for safety and efficacy as branded products. Once approved by regulatory agencies, they become competitive alternatives in the market. Health insurance plans and formulary lists often favor the use of generic medications, making them more accessible and cost-effective for patients. Pharmacies may dispense generic versions of antacids in place of branded products, unless specifically requested by the patient or healthcare provider. In response to generic competition, some pharmaceutical companies may choose to reduce the prices of their branded antacids or offer rebates and incentives to maintain their market share. Branded antacids invest heavily in marketing and branding to maintain consumer loyalty and differentiate their products. However, generic competition can still erode their market presence.

Key Market Trends

E-commerce and Online Retail

E-commerce and online retail provide a convenient way for consumers to purchase antacids. They can browse, compare products, and make purchases from the comfort of their homes, saving time and effort. Online platforms offer a broader selection of antacids, including different brands, formulations, and flavors. This variety allows consumers to choose products that best suit their preferences and needs. Online platforms provide detailed product information, customer reviews, and expert recommendations, enabling consumers to make informed choices when selecting antacids. Consumers can easily compare prices of antacids across multiple online retailers, helping them find the best deals and discounts.

Online retailers often carry niche or specialty antacid products, such as those with natural ingredients or unique formulations, catering to specific consumer preferences. Online shopping allows consumers to purchase antacids in bulk, potentially saving them money and ensuring a steady supply. Antacids can be delivered to the consumer's doorstep, eliminating the need for a trip to a physical store. This is particularly appealing for individuals with mobility issues or those living in remote areas. Some e-commerce platforms offer subscription services for antacids, ensuring regular and convenient delivery of these products to customers. Online shopping provides privacy and discretion, which can be important for individuals seeking relief from sensitive gastrointestinal issues.

Key Market Players

• GlaxoSmithKline plc
• Bayer AG
• Boehringer Ingelheim International GmbH
• Dr. Reddy's Laboratories Ltd.
• Sanofi SA
• Reckitt Benckiser Group plc
• Sun Pharmaceuticals Ltd.
• Takeda Pharmaceutical Company Limited
• Pfizer Inc.
• Procter & Gamble Co.

Report Scope:

In this report, the Global Antacids Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Antacids Market, By Type:

• Tablet
• Liquid
• Others

Antacids Market, By End-Use:

• Retail Pharmacy
• Hospital Pharmacy
• Online Pharmacy

Antacids Market, By region:

• North America
  • United States
  • Canada
  • Mexico
• Asia-Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
• Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Antacids Market.

Available Customizations:

Global Antacids Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Applications
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Antacids Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Tablet, Liquid, others)
  • 5.2.2. By End-use (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. Asia Pacific Antacids Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By End-use
  • 6.2.3. By Country
• 6.3. Asia Pacific: Country Analysis
  • 6.3.1. China Antacids Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By End-use
  • 6.3.2. India Antacids Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By End-use
  • 6.3.3. Australia Antacids Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By End-use
  • 6.3.4. Japan Antacids Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Type
      • 6.3.4.2.2. By End-use
  • 6.3.5. South Korea Antacids Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Type
      • 6.3.5.2.2. By End-use

7. Europe Antacids Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By End-use
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Antacids Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By End-use
  • 7.3.2. Germany Antacids Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By End-use
  • 7.3.3. Spain Antacids Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By End-use
  • 7.3.4. Italy Antacids Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By End-use
  • 7.3.5. United Kingdom Antacids Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By End-use

8. North America Antacids Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By End-use
  • 8.2.3. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Antacids Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By End-use
  • 8.3.2. Mexico Antacids Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By End-use
  • 8.3.3. Canada Antacids Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By End-use

9. South America Antacids Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By End-use
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Antacids Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By End-use
  • 9.3.2. Argentina Antacids Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By End-use
  • 9.3.3. Colombia Antacids Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By End-use

10. Middle East and Africa Antacids Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By End-use
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Antacids Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By End-use
  • 10.3.2. Saudi Arabia Antacids Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By End-use
  • 10.3.3. UAE Antacids Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By End-use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Antacids Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. PESTLE Analysis

16. Competitive Landscape

• 16.1. Bayer AG
  • 16.1.1. Business Overview
  • 16.1.2. Company Snapshot
  • 16.1.3. Products & Services
  • 16.1.4. Financials (As Reported)
  • 16.1.5. Recent Developments
  • 16.1.6. Key Personnel Details
  • 16.1.7. SWOT Analysis
• 16.2. GlaxoSmithKline plc
• 16.3. Boehringer Ingelheim International GmbH
• 16.4. Dr Reddy's Laboratories Ltd.
• 16.5. Sanofi SA
• 16.6. Reckitt Benckiser Group plc.
• 16.7. Sun Pharmaceuticals Ltd
• 16.8. Takeda Pharmaceutical Company Limited
• 16.9. Pfizer Inc.
• 16.10. Procter & Gamble Co.

17. Strategic Recommendations

18. About Us & Disclaimer